Male infertility research explores causality
New research on potential causes of male infertility hold key messages for urologists at this year’s AUA annual meeting, according to Craig S. Niederberger, MD, of the University of Illinois, Chicago.
This article is part of the State of Urology 2013
New research on potential causes of male infertility hold key messages for urologists at this year’s AUA annual meeting, according to Craig S. Niederberger, MD, of the University of Illinois, Chicago.
“A number of papers discuss the use of exogenous testosterone in the male causing infertility and how systemic disease such as the metabolic syndrome and cancer can be associated with male infertility. Both are really cautionary but important tales,” Dr. Niederberger said.
In the area of treatment, a must-see paper will discuss the use of stem cell transplantation potentially to treat male infertility. Abstracts about how age does not affect micro-TESE outcomes and how high DNA fragmentation in sperm as measured by the TUNEL assay may be treated by micro-TESE are also important and interesting, he said.
Here are those abstracts and others that Dr. Niederberger tagged as top abstracts from this year’s meeting:
1884: Characterization of In Vitro propagated Human Spermatogonial Stem Cells (SSCs) prior to autotransplantation
Hooman Sadri-Ardekani
1891: The impact of fresh versus frozen testicular sperm upon intracytoplasmic sperm injection (ICSI) pregnancy outcomes in men with nonobstructive azoospermia (NOA): a meta analysis
Samuel Ohlander
2287: Prevalence and clinical meaning of metabolic syndrome in European Caucasian men presenting for primary couple’s infertility
Andrea Salonia
2289: Increased risk of cancer among azoospermic men
Michael Eisenberg
2291: Testosterone Prescribing Patterns in the Male Infertility Population
Mary Samplaski
Study suggests broader use of anastrozole for male infertility
September 28th 2023If replicated with further study, the finding potentially expands noninvasive fertility treatment options and may minimize the need for expensive reproductive technology, according to lead author Scott D. Lundy, MD, PhD, of Cleveland Clinic’s Department of Urology.
